IT1161221B - Composto per il trattamento della psoriasi - Google Patents

Composto per il trattamento della psoriasi

Info

Publication number
IT1161221B
IT1161221B IT20709/83A IT2070983A IT1161221B IT 1161221 B IT1161221 B IT 1161221B IT 20709/83 A IT20709/83 A IT 20709/83A IT 2070983 A IT2070983 A IT 2070983A IT 1161221 B IT1161221 B IT 1161221B
Authority
IT
Italy
Prior art keywords
compound
psoriasis treatment
psoriasis
treatment
Prior art date
Application number
IT20709/83A
Other languages
English (en)
Other versions
IT8320709A0 (it
Inventor
Domenico Bagnaschi
Original Assignee
Ripharm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ripharm Srl filed Critical Ripharm Srl
Priority to IT20709/83A priority Critical patent/IT1161221B/it
Publication of IT8320709A0 publication Critical patent/IT8320709A0/it
Priority to DE19843414629 priority patent/DE3414629A1/de
Priority to FR8406340A priority patent/FR2545356A1/fr
Application granted granted Critical
Publication of IT1161221B publication Critical patent/IT1161221B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT20709/83A 1983-04-21 1983-04-21 Composto per il trattamento della psoriasi IT1161221B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT20709/83A IT1161221B (it) 1983-04-21 1983-04-21 Composto per il trattamento della psoriasi
DE19843414629 DE3414629A1 (de) 1983-04-21 1984-04-18 Zusammensetzung mit pharmazeutischer wirkung, neue therapeutische anwendung der zusammensetzung und verfahren zu deren herstellung
FR8406340A FR2545356A1 (fr) 1983-04-21 1984-04-20 Derive de la pyrimidine pour le traitement du psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20709/83A IT1161221B (it) 1983-04-21 1983-04-21 Composto per il trattamento della psoriasi

Publications (2)

Publication Number Publication Date
IT8320709A0 IT8320709A0 (it) 1983-04-21
IT1161221B true IT1161221B (it) 1987-03-18

Family

ID=11170887

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20709/83A IT1161221B (it) 1983-04-21 1983-04-21 Composto per il trattamento della psoriasi

Country Status (3)

Country Link
DE (1) DE3414629A1 (it)
FR (1) FR2545356A1 (it)
IT (1) IT1161221B (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016001419A1 (en) 2014-07-04 2016-01-07 Biagioni Daniele Pharmaceutical compositions for the treatment of psoriasis
IT201700006374A1 (it) * 2017-01-20 2018-07-20 Angelis Carlo De Sali di acidi retinoici per il trattamento della psoriasi

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9326699D0 (en) * 1993-12-22 1994-03-02 Celltech Ltd Chemical compounds
DE69433594T2 (de) * 1993-12-22 2004-08-05 Celltech R&D Ltd., Slough Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412571D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526243D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
US6057329A (en) * 1996-12-23 2000-05-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives
GB9705361D0 (en) 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016001419A1 (en) 2014-07-04 2016-01-07 Biagioni Daniele Pharmaceutical compositions for the treatment of psoriasis
IT201700006374A1 (it) * 2017-01-20 2018-07-20 Angelis Carlo De Sali di acidi retinoici per il trattamento della psoriasi

Also Published As

Publication number Publication date
DE3414629A1 (de) 1984-11-22
IT8320709A0 (it) 1983-04-21
FR2545356A1 (fr) 1984-11-09

Similar Documents

Publication Publication Date Title
IT1196153B (it) Composizioni migliorate per il trattamento della psoriasi
IT1161221B (it) Composto per il trattamento della psoriasi
DE3568706D1 (de) Sorbing apparatus
IT1179055B (it) Apparecchiatura di trattamento
DK562585D0 (da) Behandling
NO850330L (no) Fremgangsmaate for effektproduksjon
IT1194181B (it) Procedimento migliorato per la purificazione della tilosina
IT1199140B (it) Procedimento di trattamento della biomassa
DK325285A (da) Behandlingsmetode
DK17385D0 (da) Oxadiazinonforbindelser
IT1182133B (it) Apparecchio per trasportare bobine
FI853304A7 (fi) Yhdisteet
DK285585A (da) Tetracycliske forbindelser
DK163662C (da) N-chlorsulfonyl-2-oxindol-1-carboxamid-forbindelser
IT8421149A1 (it) Procedimento migliorato per il disproporzionamento di clorosilani
IT1168087B (it) Prodotto utile per il trattamento della psoriasi
IT1153185B (it) Composizione per il trattamento della aterosclerosi
IT1184683B (it) Procedimento per il trattamento di zircone dissociato
IT1169764B (it) Procedimento per la depurazione della s-adenosil-l- metiona
IT1197152B (it) Indurimento mediante irradiazione di composti polimerizzabili cationicamente
TR22363A (tr) Alkillestirilmis antrakinonlarin aritilmasi
IT8424134A1 (it) Composizioni per il trattamento della capigliatura
IT1175942B (it) Triazolo-benzodiazepine 1-sostituite per il trattamento di psicosi
IT8419081A1 (it) Preparato per il trattamento della cellulite
SE8402161D0 (sv) Vilbenk for ryggbehandling

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940419